Quantitative Systematic Strategies’s Aerie Pharmaceuticals AERI Stock Holding History

Quantitative Systematic Strategies’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,059	Closed	-$305K	–	419
2021 Q2	$305K	Sell	19,059 -12,560	-40%	-$215K	0.11%	327
2021 Q1	$565K	Buy	31,619 +10,877	+52%	+$188K	0.09%	347
2020 Q4	$280K	Buy	+20,742	New	+$251K	0.04%	495
2020 Q1	–	Sell	-17,650	Closed	-$427K	–	587
2019 Q4	$427K	Buy	+17,650	New	+$366K	0.06%	370
2016 Q4	–	Sell	-8,485	Closed	-$320K	–	447
2016 Q3	$320K	Buy	+8,485	New	+$187K	0.12%	248

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Quantitative Systematic Strategies's AERI Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Aerie Pharmaceuticals (AERI) in Q3 2021, closing a stake of 19,059 shares — an estimated $305K sold.

Quantitative Systematic Strategies first reported a position in AERI in Q3 2016 and held it in 5 quarters. The position peaked at $565K in Q1 2021. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.

Quantitative Systematic Strategies reported no remaining Aerie Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 19,059 Aerie Pharmaceuticals shares in Q3 2021, an estimated $305K.
Quantitative Systematic Strategies first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 5 quarters.
Quantitative Systematic Strategies's Aerie Pharmaceuticals position peaked at $565K in Q1 2021.
137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.